No CrossRef data available.
Published online by Cambridge University Press: 24 November 2017
ß-adrenergic agonists are powerful repartitioning agents, increasing muscle protein accretion and reducing fat deposition in a variety of species. Their exact mode of action is not fully understood but some of their effects are similar to those elicited by exogenous growth hormone administration. Whilst there are few reports of plasma growth hormone (GH) concentrations being elevated in animals treated with ß-agonists, several in vitro studies have clearly demonstrated a direct stimulation of GH release from perifused or cultured pituitary or adenohypophyseal cells on administration of these agents. More recently, a brief, rapid rise in plasma GH has been demonstrated in rats infused intra-atrially with isoproterenol and this was sustained when the animals were pre-treated with somatotropin release inhibitory factor (somatostatin; SRIF) antiserum. This raises the possibility that ß-adrenergic agonists do stimulate GH release in vivo but that this response is rapidly counteracted by SRIF release.
The aim of this work was to attempt to enhance the repartitioning effect of ß-adrenergic agonists by immunizing young cattle against SRIF whilst administering cimaterol.